Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular EdemaCompleted
NCT03622593Phase 3Updated Jul 11, 2025
Sponsor: Hoffmann-La Roche
Diabetic Macular Edema
United States, Argentina, Australia, Brazil, Canada +19 more
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)Completed
NCT05096221Phase 3Updated Jul 8, 2025
Sponsor: Sarepta Therapeutics, Inc.
Duchenne Muscular Dystrophy
United States, Belgium, Germany, Hong Kong, Italy +4 more
A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081Completed
NCT06809608Phase 1Updated Jul 8, 2025
Sponsor: Hoffmann-La Roche
Healthy Participants
Netherlands
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple SclerosisCompleted
NCT03972306Phase 1Updated Jul 8, 2025
Sponsor: Hoffmann-La Roche
Multiple Sclerosis (MS)
United States
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsCompleted
NCT03969212Phase 3Updated Jul 4, 2025
Sponsor: Hoffmann-La Roche
Influenza
United States, Bulgaria, China, Costa Rica, Greece +11 more
Comparison Between Different Sampling Sites for Detection of Respiratory VirusesCompleted
NCT06743750N/AUpdated Jul 4, 2025
Sponsor: Insel Gruppe AG, University Hospital Bern
Respiratory Tract Infection Viral
Switzerland
A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal CarcinomaCompleted
NCT03519295Phase 2Updated Jun 27, 2025
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Anal Cancer
France
Can Resistance Enhance Selection of Treatment? (CREST)Completed
NCT00262717NAUpdated Jun 26, 2025
Sponsor: Kirby Institute
HIV Infection
Australia
An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerCompleted
NCT01932125Phase 4Updated Jun 26, 2025
Sponsor: Hoffmann-La Roche
Ovarian Neoplasms · Peritoneal Neoplasms · Fallopian Tube Neoplasms
India
Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular InvolvementActive Not Recruiting
NCT04888221Phase 3Updated Jun 25, 2025
Sponsor: Assistance Publique - Hôpitaux de Paris
Giant Cell Arteritis · Neurovascular Disorder
France
A Study of Vemurafenib in Metastatic Melanoma Participants With Brain MetastasesCompleted
NCT01378975Phase 2Updated Jun 25, 2025
Sponsor: Hoffmann-La Roche
Malignant Melanoma
United States, Australia, Canada, France, Germany +5 more
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin LymphomaCompleted
NCT02750670Phase 2Updated Jun 22, 2025
Sponsor: University Health Network, Toronto
Lymphoma, Non-Hodgkin's
Canada
A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.Active Not Recruiting
NCT03539744Phase 3Updated Jun 19, 2025
Sponsor: AbbVie
Multiple Myeloma
United States, Australia, Canada, China, Czechia +15 more
Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN StudyCompleted
NCT04400474Phase 2Updated Jun 19, 2025
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Neuroendocrine Tumor · Anaplastic Thyroid Cancer · Adenocarcinoma · Pheochromocytoma
Spain
A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC)Withdrawn
NCT06816017Phase 1Updated Jun 16, 2025
Sponsor: Hoffmann-La Roche
Non-muscle Invasive Bladder Cancer
Australia, Italy, Malaysia, Netherlands, Poland +1 more
Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for OxaliplatinActive Not Recruiting
NCT05118724Phase 2Updated Jun 15, 2025
Sponsor: AIO-Studien-gGmbH
Colorectal Cancer
Germany
Exploring Novel Biomarkers for Emphysema DetectionRecruiting
NCT05825261N/AUpdated Jun 13, 2025
Sponsor: Maastricht University
Copd · Emphysema
Netherlands
A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)Terminated
NCT05256134Phase 3Updated Jun 12, 2025
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Canada, Italy +5 more
"neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast CancerTerminated
NCT06067061Phase 1, Phase 2Updated Jun 11, 2025
Sponsor: Institut Curie
Triple Negative Breast Neoplasms
France
Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)Completed
NCT02401503Phase 2Updated Jun 10, 2025
Sponsor: German CLL Study Group
Chronic Lymphocytic Leucemia
Germany
Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCLNot Yet Recruiting
NCT07012980Phase 2Updated Jun 10, 2025
Sponsor: Shanghai Zhongshan Hospital
Diffuse Large B-Cell Lymphoma
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Active Not Recruiting
NCT03448835Phase 2Updated Jun 8, 2025
Sponsor: The Netherlands Cancer Institute
Stomach Cancer · Gastro Esophageal Junction Cancer
Netherlands
Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)Active Not Recruiting
NCT04017455Phase 2Updated Jun 8, 2025
Sponsor: The Netherlands Cancer Institute
Rectal Cancer
Netherlands
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate CancerCompleted
NCT03072238Phase 3Updated Jun 6, 2025
Sponsor: Hoffmann-La Roche
Metastatic Prostate Cancer
United States, Australia, Austria, Belgium, Brazil +21 more
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-NetherlandsRecruiting
NCT06193252NAUpdated Jun 3, 2025
Sponsor: Radboud University Medical Center
Parkinson Disease · Prodromal Stage · Neurodegenerative Diseases · Parkinsonian Disorders
Netherlands

Previous page Next page